Nov. 15 (Bloomberg) -- Shares of Orion Oyj, the Nordic region’s third-largest drugmaker, dropped as much as 14 percent after researchers said the Simdax heart failure treatment caused some complications and didn’t lower death rates.
Nov. 15 (Bloomberg) -- Shares of Orion Oyj, the Nordic region’s third-largest drugmaker, dropped as much as 14 percent after researchers said the Simdax heart failure treatment caused some complications and didn’t lower death rates.
